StonvexLoading…
StonvexCore line items from CC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.38B | $5.81B | $1.50B | $1.61B |
Operating Income | $-22.00M | $-277.00M | $38.00M | $-249.00M |
Net Income | $-29.00M | $-386.00M | $-339.00M | $-380.00M |
EPS (Diluted) | $-0.19 | $-2.57 | $-2.26 | $-2.53 |
Total Assets | $7.27B | $7.38B | $7.55B | $7.46B |
Total Liabilities | $7.05B | $7.13B | $7.27B | $7.23B |
Cash & Equivalents | $563.00M | $670.00M | $613.00M | $502.00M |
Free Cash Flow OCF − CapEx | $-93.00M | $51.00M | $-41.00M | $-146.00M |
Shares Outstanding | 150.36M | 149.89M | 149.87M | 149.70M |